Find methods for your needs

Refine by Feature

No filters available

Displaying 1-5 of 5 results for Tag: Aspirin

Items per page:
Sort by

USP assay of aspirin using a Thermo Scientific Acclaim 120 C18 column

Instrument Type: HPLC

The Thermo Scientific Acclaim 120 C18 column is applied for the USP assay of aspirin, with UV detection at 280 nm.

Improved analysis of active pharmaceutical ingredients in a pain-relief medicine using a Thermo Scientific Acclaim Mixed-Mode WAX-1 HPLC column

Instrument Type: HPLC

The Thermo Scientific HPLC system was applied for the analysis of active pharmaceutical ingredients (APIs) in a pain-relief medicine. The separation was performed on a Thermo Scientific Acclaim Mixed-Mode WAX-1 column with UV detection at 220 nm.

Rapid separation of analgesic compounds using a Thermo Scientific Accucore Urea-HILIC HPLC column

Instrument Type: HPLC

The Thermo Scientific HPLC system is applied for the determination of analgesic compounds aspirin, acetaminophen and salicylic acid. The separation is performed on a Thermo Scientific Accucore Urea-HILIC HPLC column, with UV detection at 230 nm.

Fast analysis of non-steroidal anti-inflamatory drugs (NSAIDs) using a Thermo Scientific Syncronis C18 HPLC column

Instrument Type: HPLC

The Thermo Scientific HPLC system is applied for the determination of non-steroidal anti-inflamatory drugs (NSAIDs). The separation is performed on a Thermo Scientific Syncronis C18 HPLC column, with UV detection at 260 nm.

Ultrafast analysis of Aspirin by UHPLC using a Thermo Scientific Acclaim 120 C18 2.2 µm HPLC column

Instrument Type: UHPLC

The Thermo Scientific UltiMate 3000 RSLC system is applied for the rapid determination of aspirin. The separation is performed on a Thermo Scientific Acclaim 120 C18 2.2 µm column in under 1.5 mins, with UV detection at 280 nm. This application is a speed-up of the USP method for the assay of Aspirin. Simply recomputing the operating parameters for a 2.1x50 mm column leads to a 10-fold increase in throughput and 96% savings in mobile phase per assay, whilst maintaining baseline separation.